These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11068883)

  • 21. Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab.
    Waetzig GH; Rosenstiel P; Nikolaus S; Seegert D; Schreiber S
    Gastroenterology; 2003 Aug; 125(2):633-4; author reply 635-6. PubMed ID: 12891581
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of NIMA protein kinase in Aspergillus nidulans.
    Ye XS; Xu G; Fincher RR; Osmani SA
    Methods Enzymol; 1997; 283():520-32. PubMed ID: 9251045
    [No Abstract]   [Full Text] [Related]  

  • 23. Peptide microarrays for profiling of serine/threonine kinase activity of recombinant kinases and lysates of cells and tissue samples.
    Hilhorst R; Houkes L; Mommersteeg M; Musch J; van den Berg A; Ruijtenbeek R
    Methods Mol Biol; 2013; 977():259-71. PubMed ID: 23436369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docking domains and substrate-specificity determination for MAP kinases.
    Sharrocks AD; Yang SH; Galanis A
    Trends Biochem Sci; 2000 Sep; 25(9):448-53. PubMed ID: 10973059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinase-catalyzed biotinylation for phosphoprotein detection.
    Green KD; Pflum MK
    J Am Chem Soc; 2007 Jan; 129(1):10-1. PubMed ID: 17199263
    [No Abstract]   [Full Text] [Related]  

  • 26. Structure of the human protein kinase MPSK1 reveals an atypical activation loop architecture.
    Eswaran J; Bernad A; Ligos JM; Guinea B; Debreczeni JE; Sobott F; Parker SA; Najmanovich R; Turk BE; Knapp S
    Structure; 2008 Jan; 16(1):115-24. PubMed ID: 18184589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational restraint is a critical determinant of unnatural nucleotide recognition by protein kinases.
    Ulrich SM; Sallee NA; Shokat KM
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3223-7. PubMed ID: 12372539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a small-molecule inhibitor of the KIX-KID interaction.
    Li BX; Xiao X
    Chembiochem; 2009 Nov; 10(17):2721-4. PubMed ID: 19810079
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same.
    Sahu V; Nigam L; Agnihotri V; Gupta A; Shekhar S; Subbarao N; Bhaskar S; Dey S
    Cancer Res Treat; 2019 Jan; 51(1):313-325. PubMed ID: 29747487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new autoinhibited kinase conformation reveals a salt-bridge switch in kinase activation.
    Wei Q; Yang S; Li D; Zhang X; Zheng J; Jia Z
    Sci Rep; 2016 Jun; 6():28437. PubMed ID: 27324091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation.
    Aubol BE; Plocinik RM; Keshwani MM; McGlone ML; Hagopian JC; Ghosh G; Fu XD; Adams JA
    Biochem J; 2014 Aug; 462(1):143-52. PubMed ID: 24869919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity.
    Kotzka J; Knebel B; Haas J; Kremer L; Jacob S; Hartwig S; Nitzgen U; Muller-Wieland D
    PLoS One; 2012; 7(2):e32609. PubMed ID: 22384276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a novel MK3 splice variant from murine ventricular myocardium.
    Moïse N; Dingar D; Mamarbachi AM; Villeneuve LR; Farhat N; Gaestel M; Khairallah M; Allen BG
    Cell Signal; 2010 Oct; 22(10):1502-12. PubMed ID: 20570725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PIN phosphorylation is sufficient to mediate PIN polarity and direct auxin transport.
    Zhang J; Nodzynski T; Pencík A; Rolcík J; Friml J
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):918-22. PubMed ID: 20080776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlated mutation analysis on the catalytic domains of serine/threonine protein kinases.
    Xu F; Du P; Shen H; Hu H; Wu Q; Xie J; Yu L
    PLoS One; 2009 Jun; 4(6):e5913. PubMed ID: 19526051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuning a three-component reaction for trapping kinase substrate complexes.
    Statsuk AV; Maly DJ; Seeliger MA; Fabian MA; Biggs WH; Lockhart DJ; Zarrinkar PP; Kuriyan J; Shokat KM
    J Am Chem Soc; 2008 Dec; 130(51):17568-74. PubMed ID: 19053485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs.
    Sheridan DL; Kong Y; Parker SA; Dalby KN; Turk BE
    J Biol Chem; 2008 Jul; 283(28):19511-20. PubMed ID: 18482985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of recombinant tristetraprolin in vitro.
    Cao H; Lin R
    Protein J; 2008 Apr; 27(3):163-9. PubMed ID: 18071886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conservation, variability and the modeling of active protein kinases.
    Knight JD; Qian B; Baker D; Kothary R
    PLoS One; 2007 Oct; 2(10):e982. PubMed ID: 17912359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis.
    Cao H; Deterding LJ; Venable JD; Kennington EA; Yates JR; Tomer KB; Blackshear PJ
    Biochem J; 2006 Feb; 394(Pt 1):285-97. PubMed ID: 16262601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.